176 related articles for article (PubMed ID: 37476181)
1. Analysis of Aldehyde Dehydrogenase 2 as a Prognostic Marker Associated with Immune Cell infiltration and Chemotherapy Efficacy in Head and Neck Squamous Cell Carcinoma.
Lin YH; Yang YF; Liao JB; Chang TS; Janesha UGS; Shiue YL
J Cancer; 2023; 14(10):1689-1706. PubMed ID: 37476181
[No Abstract] [Full Text] [Related]
2. Identifying the Therapeutic and Prognostic Role of the CD8+ T Cell-Related Gene ALDH2 in Head and Neck Squamous Cell Carcinoma.
Zhang H; Li Z; Zheng Y
Cancer Inform; 2022; 21():11769351221139252. PubMed ID: 36570380
[TBL] [Abstract][Full Text] [Related]
3. Exploring ALDH2 expression and immune infiltration in HNSC and its correlation of prognosis with gender or alcohol intake.
Yao S; Yin X; Chen T; Chen W; Zuo H; Bi Z; Zhang X; Jing Y; Pang L; Cheng H
Sci Rep; 2022 Feb; 12(1):2504. PubMed ID: 35169188
[TBL] [Abstract][Full Text] [Related]
4. Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer.
Murphy RM; Tasoulas J; Porrello A; Carper MB; Tsai YH; Coffey AR; Kumar S; Zeng PY; Schrank TP; Midkiff BR; Cohen S; Salazar AH; Hayward MC; Hayes DN; Olshan A; Gupta GP; Nichols AC; Yarbrough WG; Pecot CV; Amelio AL
Cancer Res Commun; 2022 Sep; 2(9):987-1004. PubMed ID: 36148399
[TBL] [Abstract][Full Text] [Related]
5. Prognostic biomarker GSTK1 in head and neck squamous cell carcinoma and its correlation with immune infiltration and DNA methylation.
Feng Y; Zhou YH; Zhao J; Su XL; Chen NX; Zhao YQ; Ye Q; Hu J; Ou-Yang ZY; Zhong MM; Yang YF; Han PJ; Guo Y; Feng YZ
Front Genet; 2023; 14():1041042. PubMed ID: 36936420
[No Abstract] [Full Text] [Related]
6. FDCSP Is an Immune-Associated Prognostic Biomarker in HPV-Positive Head and Neck Squamous Carcinoma.
Wu Q; Shao T; Huang G; Zheng Z; Jiang Y; Zeng W; Lv X
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291667
[No Abstract] [Full Text] [Related]
7. Comprehensive analysis reveals CCDC60 as a potential biomarker correlated with prognosis and immune infiltration of head and neck squamous cell carcinoma.
Liu Z; Chen S; Jia W; Qian Y; Yang X; Zhang M; Fang T; Liu H
Front Oncol; 2023; 13():1113781. PubMed ID: 37064086
[TBL] [Abstract][Full Text] [Related]
8. Spermine synthase (
Pan X; Xue L; Sun Y
Ann Transl Med; 2022 Nov; 10(22):1213. PubMed ID: 36544695
[TBL] [Abstract][Full Text] [Related]
9. CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study.
Li C; Chen S; Liu C; Mo C; Gong W; Hu J; He M; Xie L; Hou X; Tang J; Ou M
Hereditas; 2022 Sep; 159(1):37. PubMed ID: 36167571
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
[TBL] [Abstract][Full Text] [Related]
11. [Effect of
Yao YF; Liu W; Zhou ML; Qiu TL; Wang K
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 May; 53(3):457-465. PubMed ID: 35642155
[TBL] [Abstract][Full Text] [Related]
12. Identification of the HNSC88 Molecular Signature for Predicting Subtypes of Head and Neck Cancer.
Chuang YH; Lin CY; Lee JC; Lee CH; Liu CL; Huang SH; Lee JY; Lai WS; Yang JM
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685875
[TBL] [Abstract][Full Text] [Related]
13. FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis.
Huang J; Liang B; Wang T
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34269372
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cell-based signature: Prognostic analysis in head and neck squamous cell carcinoma.
Guo Z; Zhao Y; Xu M; Zhao L; Wang X
J Gene Med; 2024 Feb; 26(2):e3671. PubMed ID: 38384136
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic analysis of BGN in head and neck squamous cell carcinoma.
Zhao L; Liang J; Zhong W; Han C; Liu D; Chen X
Gene; 2022 Jun; 827():146461. PubMed ID: 35358652
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy.
Chen YP; Wang YQ; Lv JW; Li YQ; Chua MLK; Le QT; Lee N; Colevas AD; Seiwert T; Hayes DN; Riaz N; Vermorken JB; O'Sullivan B; He QM; Yang XJ; Tang LL; Mao YP; Sun Y; Liu N; Ma J
Ann Oncol; 2019 Jan; 30(1):68-75. PubMed ID: 30407504
[TBL] [Abstract][Full Text] [Related]
17. Clinical powers of Aminoacyl tRNA Synthetase Complex Interacting Multifunctional Protein 1 (AIMP1) for head-neck squamous cell carcinoma.
Li Y; Liu H
Cancer Biomark; 2022; 34(3):359-374. PubMed ID: 35068446
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of intra- and peritumoral immune cell subpopulations in head and neck squamous cell carcinomas - comprehensive analysis of the TCGA-HNSC cohort and immunohistochemical validation on 101 patients.
Knebel M; Körner S; Kühn JP; Wemmert S; Brust L; Smola S; Wagner M; Bohle RM; Morris LGT; Pandey A; Schick B; Linxweiler M
Front Immunol; 2023; 14():1172768. PubMed ID: 37383237
[TBL] [Abstract][Full Text] [Related]
19. Identification of the Potential Correlation between Tumor Protein 73 and Head and Neck Squamous Cell Carcinoma.
Chen Y
Dis Markers; 2022; 2022():6410113. PubMed ID: 35756491
[TBL] [Abstract][Full Text] [Related]
20. The characteristics and clinical relevance of tumor fusion burden in head and neck squamous cell carcinoma.
He L; Ren D; Lv G; Mao B; Wu L; Liu X; Gong L; Liu P
Cancer Med; 2023 Jan; 12(1):852-861. PubMed ID: 35621268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
